Spero Therapeutics Inc. (SPRO)
0.79
0.01 (1.86%)
At close: Mar 03, 2025, 12:21 PM
Spero Therapeutics Revenue
Spero Therapeutics reported an annual revenue of $96.73M, reflecting a 99.13% growth. For the quarter ending September 30, 2024, Spero Therapeutics generated $7.82M in revenue.
Revenue (ttm)
$96.73M
Revenue Growth
99.13%
Price / Sales Ratio
0.8
Revenue / Employee
$2.1M
Employees
46
Market Cap
42.8M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| 2023-12-31 | 96.73M | +99.13% |
| 2022-12-31 | 48.58M | +166.10% |
| 2021-12-31 | 18.26M | +95.67% |
| 2020-12-31 | 9.33M | n/a |